...
首页> 外文期刊>Virology >Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.
【24h】

Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.

机译:具有复制缺陷的重组腺病毒的单次口服免疫引发长寿命的转基因特异性细胞和体液免疫应答。

获取原文
获取原文并翻译 | 示例

摘要

Oral-gastric delivery of vaccines is a preferred route of immunization and is particularly relevant to the development of vaccine-vector systems. We have investigated the ability of a replication deficient (E1-deleted) adenovirus construct (RAd68), which efficiently expresses the measles virus nucleocapsid (N) protein under the control of the strong HCMV IE promoter, to elicit antibody and cytotoxic T cell (CTL) responses in mice following intragastric administration. Measles virus N protein-specific CTL memory and serum antibody responses were analyzed in a total of 140 mice at time points 2-51 weeks after immunization either with a single dose of 10(8) pfu RAd68 or with a fivefold higher dose. Of the 20 animals analyzed in the first 4-week period following low-dose immunization, 6 mounted low-level splenic CTL responses while 13 animals had CTL in the mesenteric lymph nodes. Splenic CTL responses were largely undetectable at later times. Only 23% of low-dose-immunized mice made serum antibody responses and these were generally of low magnitude and frequently of short duration. In contrast, the majority of animals immunized orally with 5 x 10(8) pfu RAd68 mounted splenic CTL responses (70%) and/or antibody responses (89%). Notably, these responses were stronger and of greater duration than those seen following immunization at the lower dose. Gut mucosal immunization with replication deficient adenoviruses is a promising approach, not only for the development of complementary measles vaccine strategies which may be required for measles virus eradication, but also generally for vaccination against other infections.
机译:疫苗的口服途径是一种首选的免疫途径,尤其与疫苗载体系统的开发有关。我们研究了复制缺陷型(E1缺失)腺病毒构建体(RAd68)的能力,该构建体在强HCMV IE启动子的控制下有效表达了麻疹病毒核衣壳(N)蛋白,从而引起抗体和细胞毒性T细胞(CTL) )胃内给药后小鼠的反应。在免疫后2至51周的时间点,共140只小鼠用单剂量10(8)pfu RAd68或高五倍的剂量分析了麻疹病毒N蛋白特异性CTL记忆力和血清抗体反应。在低剂量免疫后的最初4周内分析的20只动物中,有6只安装了低水平的脾CTL反应,而13只动物在肠系膜淋巴结中有CTL。脾脏的CTL反应在以后的时间里基本上无法检测到。低剂量免疫的小鼠中只有23%产生血清抗体反应,并且这些反应通常幅度较小,且持续时间短。相反,大多数动物用5 x 10(8)pfu RAd68口服免疫接种了脾脏CTL应答(70%)和/或抗体应答(89%)。值得注意的是,这些反应比以较低剂量免疫后看到的反应更强,持续时间更长。用复制缺陷型腺病毒进行肠粘膜免疫是一种很有前途的方法,不仅用于开发补充麻疹疫苗的策略(可能需要根除麻疹病毒),而且通常还用于针对其他感染的疫苗接种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号